BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29391288)

  • 1. Differences in Longitudinal Health Utility between Stereotactic Body Radiation Therapy and Surgery in Stage I Non-Small Cell Lung Cancer.
    Wolff HB; Alberts L; Kastelijn EA; Lissenberg-Witte BI; Twisk JW; Lagerwaard FJ; Senan S; El Sharouni SY; Schramel FMNH; Coupé VMH
    J Thorac Oncol; 2018 May; 13(5):689-698. PubMed ID: 29391288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported Outcomes After the Treatment of Early Stage Non-small-cell Lung Cancer With Stereotactic Body Radiotherapy Compared With Surgery.
    Alberts L; Wolff HB; Kastelijn EA; Lagerwaard FJ; Hofman FN; Sharouni SYE; Schramel FMNH; Coupe VMH
    Clin Lung Cancer; 2019 Sep; 20(5):370-377.e3. PubMed ID: 31182416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.
    Paix A; Noel G; Falcoz PE; Levy P
    Radiother Oncol; 2018 Sep; 128(3):534-540. PubMed ID: 29706462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly.
    Wang P; Zhang D; Guo XG; Li XM; Du LH; Sun BJ; Fang XQ; Guo YH; Guo J; An L; Qu GP; Liu CT
    Medicine (Baltimore); 2016 Dec; 95(52):e5723. PubMed ID: 28033277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis.
    Louie AV; Rodrigues G; Hannouf M; Zaric GS; Palma DA; Cao JQ; Yaremko BP; Malthaner R; Mocanu JD
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):964-73. PubMed ID: 20932688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Health-related Quality of Life among Individuals Considering Treatment for Stage I Non-Small-Cell Lung Cancer.
    Nugent SM; Golden SE; Hooker ER; Sullivan DR; Thomas CR; Deffebach ME; Sukumar MS; Schipper PH; Tieu BH; Moghanaki D; Wisnivesky J; Samson P; Robinson C; Slatore CG
    Ann Am Thorac Soc; 2020 Aug; 17(8):988-997. PubMed ID: 32433897
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of stereotactic body radiation therapy versus video assisted thoracic surgery in medically operable stage I non-small cell lung cancer: A modeling study.
    Wolff HB; Alberts L; van der Linden N; Bongers ML; Verstegen NE; Lagerwaard FJ; Hofman FN; Uyl-de Groot CA; Senan S; El Sharouni SY; Kastelijn EA; Schramel FMNH; Coupé VMH
    Lung Cancer; 2020 Mar; 141():89-96. PubMed ID: 31982640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC.
    Ackerson BG; Tong BC; Hong JC; Gu L; Chino J; Trotter JW; D'Amico TA; Torok JA; Lafata K; Chang C; Kelsey CR
    Lung Cancer; 2018 Nov; 125():185-191. PubMed ID: 30429018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery or stereotactic body radiotherapy for elderly stage I lung cancer? A propensity score matching analysis.
    Miyazaki T; Yamazaki T; Nakamura D; Sato S; Yamasaki N; Tsuchiya T; Matsumoto K; Kamohara R; Hatachi G; Nagayasu T
    Surg Today; 2017 Dec; 47(12):1476-1483. PubMed ID: 28447170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching.
    Dong B; Wang J; Zhu X; Chen Y; Xu Y; Shao K; Zheng L; Ying H; Chen M; Cao J
    Radiat Oncol; 2019 Nov; 14(1):195. PubMed ID: 31699115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer.
    Hamaji M; Chen F; Matsuo Y; Kawaguchi A; Morita S; Ueki N; Sonobe M; Nagata Y; Hiraoka M; Date H
    Ann Thorac Surg; 2015 Apr; 99(4):1122-9. PubMed ID: 25661580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery.
    Varlotto J; Fakiris A; Flickinger J; Medford-Davis L; Liss A; Shelkey J; Belani C; DeLuca J; Recht A; Maheshwari N; Barriger R; Yao N; DeCamp M
    Cancer; 2013 Aug; 119(15):2683-91. PubMed ID: 23605504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
    Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
    Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision Regret among Patients with Early-stage Lung Cancer Undergoing Radiation Therapy or Surgical Resection.
    Sullivan DR; Wisnivesky JP; Nugent SM; Stone K; Farris MK; Kern JA; Swanson S; Smith CB; Rosenzweig K; Slatore CG
    Clin Oncol (R Coll Radiol); 2023 Jun; 35(6):e352-e361. PubMed ID: 37031075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The patient's perspective on stereotactic body radiation therapy (SBRT) vs. surgery for treatment of early stage non-small cell lung cancer (NSCLC).
    Shaverdian N; Wang PC; Steinberg M; Lee P
    Lung Cancer; 2015 Nov; 90(2):230-3. PubMed ID: 26358313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review.
    Tandberg DJ; Tong BC; Ackerson BG; Kelsey CR
    Cancer; 2018 Feb; 124(4):667-678. PubMed ID: 29266226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.
    Shah A; Hahn SM; Stetson RL; Friedberg JS; Pechet TT; Sher DJ
    Cancer; 2013 Sep; 119(17):3123-32. PubMed ID: 23720093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis.
    Scotti V; Bruni A; Francolini G; Perna M; Vasilyeva P; Loi M; Simontacchi G; Viggiano D; Lanfranchi B; Gonfiotti A; Topulli J; Olmetto E; Maragna V; Ferrari K; Bonti V; Comin C; Balduzzi S; D'Amico R; Lohr F; Voltolini L; Livi L
    Clin Lung Cancer; 2019 Jan; 20(1):e53-e61. PubMed ID: 30348595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma.
    Kann BH; Verma V; Stahl JM; Ross R; Dosoretz AP; Shafman TD; Gross CP; Park HS; Yu JB; Decker RH
    Radiother Oncol; 2019 May; 134():44-49. PubMed ID: 31005223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery.
    Palma D; Visser O; Lagerwaard FJ; Belderbos J; Slotman B; Senan S
    Radiother Oncol; 2011 Nov; 101(2):240-4. PubMed ID: 21775007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.